Health Disparities and Child Development After Prematurity

Pediatric Annals
|October 12, 2017
PubMed

Insights

Preterm infants need ongoing developmental surveillance beyond infancy. Disadvantaged preterm children face significant disparities in support access and long-term academic success.

Area of Science:

  • Neonatal development and long-term outcomes
  • Pediatric developmental surveillance
  • Early intervention services

Background:

  • Preterm neonates require sequential surveillance for developmental disorders up to age 5 and beyond.
  • Current follow-up often focuses narrowly on major disabilities (cerebral palsy, blindness, deafness) in high-risk infants.
  • Barriers exist for diverse families accessing early intervention and education supports.

Purpose of the Study:

  • Highlight research on the long-term impact of preterm birth.
  • Focus on disparities in resource access and early educational trajectories.
  • Provide recommendations for proactive management strategies.

Main Methods:

  • Review of recent research on long-term impacts of preterm birth.
  • Analysis of disparities in resource access and kindergarten entry outcomes.
  • Identification of key recommendations for at-risk children's success.

Main Results:

  • Children born preterm, especially from disadvantaged backgrounds, face significant disparities.
  • Disparities are evident in access to comprehensive support and long-term academic outcomes.
  • Early educational trajectories are negatively impacted by socioeconomic factors.

Conclusions:

  • Sequential surveillance is crucial for all preterm infants to address a spectrum of developmental needs.
  • Addressing socioeconomic disparities is essential for equitable outcomes in preterm children.
  • Ten key recommendations are proposed for proactive management to ensure long-term academic, behavioral, and social success.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
350
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
298
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
346
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
269